Release Date: January 10, 2023 Valid for Credit through: January 10, 2024 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants from Biogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, physician assistants, and …
Author Archives: Jenn Pichardo
Contemporary Considerations in Multiple Sclerosis Treatment:
Building Clinical Confidence: Evidence-based Care for People Living with MS
Released On: December 5, 2022 Expires On: December 5, 2023 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. This activity can take up to 75 minutes to complete. Target Audience Neurologists, primary …
Continue reading “Building Clinical Confidence: Evidence-based Care for People Living with MS”
Collaborating Across the Continuum™: Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy
Release Date: November 30, 2022 Expiration Date: November 30, 2023 Faculty: Stephen Krieger, MD, FAAN Jacci Bainbridge, PharmD, FCCP Denise Bruen, ANP-BC, MSN, MSCN Activity Overview Following the success of anti-CD20 antibodies in the treatment of multiple sclerosis (MS), there has been a shift in understanding of its pathophysiology. B cells have been identified as …
What Would You Do? An Interactive and Evidence-Based Educational Session on MS Treatment Approaches
Release Date: December 13, 2022 Valid for Credit through: January 13, 2024 This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBiogen and Genentech. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — maximum of 1.0 contact …
Preventing Common Secondary Conditions in Advanced MS: Urinary Tract Infections
Tuesday, November 29, 2022 – 6 pm (ET) Target Audience This activity has been designed to meet the educational needs of nursing professionals, physicians, advanced practice clinicians, social workers, and other members of the healthcare team involved in the management of patients with MS. Learning Objectives Upon completing this activity, participants should be better able …
Continue reading “Preventing Common Secondary Conditions in Advanced MS: Urinary Tract Infections”
IJMSC: Clinical and Research Applications of the Electronic Medical Record in Multiple Sclerosis: A Narrative Review of Current Uses and Future Applications
Release Date: Nov. 1, 2022 Valid for Credit through: Nov. 1, 2023 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, pharmacists, mental health professionals, social workers, and other health care providers involved in the research …
Contemporary Considerations in Multiple Sclerosis Treatment: A Post-Pandemic Educational Curriculum
Tuesday, December 6, 2022 7:00 pm – 8:15 pm EST With featured speaker: Robert K. Shin, MD, FANA, FAAN Professor, Department of Neurology MedStar Georgetown University Hospital Washington, D.C. This timely live webinar is designed to improve clinicians’ knowledge and competence related to …
IJMSC: Characterizing Relationships Between Cognitive, Mental, and Physical Health and Physical Activity Levels in Persons With Multiple Sclerosis
Release Date: Sept. 1, 2022 Valid for Credit through: Sept. 1, 2023 Activity Available Online: To access the article and evaluation online, go to https://www.highmarksce.com/mscare. Target Audience: The target audience for this activity is physicians, advanced practice clinicians, nursing professionals, mental health professionals, rehabilitation professionals, and other health care providers involved in the management of …
What Can Biomarkers Tell Us? Modern Tools to Assist Navigating Prognosis, Monitoring, and Therapeutic Decision-Making in the Long-Term Management of Multiple Sclerosis
Release Date: 08/09/2022 Expiration Date: 08/09/2023 Overview This symposium, originally held in conjunction with the 2022 Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting, is designed to elucidate the perspectives of noted experts on existing and rising indicators of MS prognosis and/or disease activity (e.g., serum biomarkers, lesion topography). During the program, invited faculty advocate …
Neuromyelitis Optica Spectrum Disorder: Novel Therapeutic Landscape and Impact on Treatment Paradigms
Release Date: 7/28/2022 Expiration Date: 7/27/2023 Provider Statement This continuing education activity is provided by Support Statement This activity is supported by an educational grant from Horizon Therapeutics USA, Inc. There is no non-commercial support for this activity. Education activities are distinguished as separate from endorsement of commercial products. When commercial products are displayed, participants …